The President’s Emergency Plan for AIDS Relief (PEPFAR) has been and continues to be subject to a range of Congressional reporting requirements. These include enduring (ongoing) requirements as well as time-bound requirements, through both PEPFAR’s authorizations as well as appropriations legislation in some years.
This document provides a list of reporting requirements identified in PEPFAR’s authorizing legislation over time as well as other key legislation. Table 1 includes current requirements and requests. Table 2 includes past requirements and requests that are no longer in effect. While this document lists most such requirements, it may not be exhaustive.1
Current PEPFAR Reporting Requirements
Abbreviations used are:<br>
• United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003: “<b>Leadership Act</b>” (<a href="https://www.congress.gov/bill/108th-congress/house-bill/1298">P.L. 108-25</a>)<br>
• Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: “<b>Lantos-Hyde Act</b>” (<a href="https://www.congress.gov/bill/110th-congress/house-bill/5501">P.L. 110-293</a>)<br>
• PEPFAR Stewardship and Oversight Act of 2013: “<b>PEPFAR Stewardship Act</b>” (<a href="https://www.congress.gov/bill/113th-congress/senate-bill/1545">P.L. 113-56</a>)<br>
• PEPFAR Extension Act of 2018: “<b>PEPFAR Extension Act</b>” (<a href="https://www.congress.gov/bill/115th-congress/house-bill/6651">P.L. 115-305</a>)<br>
• Department of State, Foreign Operations, and Related Programs Appropriations Act, 2024: “<b>Extension of Certain Requirements of PEPFAR, 2024</b>” (<a href="https://www.congress.gov/bill/118th-congress/house-bill/2882">P.L. 118-47</a>)<br>
• National Security, Department of State, and Related Programs Appropriations Act, 2026, as part of Consolidated Appropriations Act, 2026: “<b>NSRP Act, 2026</b>” (<a href="https://www.congress.gov/bill/119th-congress/house-bill/7148">P.L. 119-75</a>)<br>
Where only a year is referenced, the year refers to the corresponding Acts above.<br>
<br>
#: Defines (or maintains definition of) partner country as a country that receives a minimum of $5 million in HIV/AIDS assistance from the U.S. Government in the previous fiscal year, for the purposes of the annual report and the Treatment Provider Study.<br>
^ Requirements in the explanatory statement are that in “developing such strategy, the Secretary shall consider: (1) a phased approach for reducing reliance upon United States bilateral funding in countries deemed ready for transition, informed by clearly defined, transparent economic and programmatic criteria benchmarks; (2) the health system readiness in each country, to be assessed on an annual basis, including the degree to which partner-led public health systems have the capacity to provide HIV services and based on jointly developed agreements that define clear roles and responsibilities, milestones, and projected annual funding reductions for PEPFAR-supported activities; (3) a plan to coordinate United States Government global health investments including grants and loans, the participation of United States development finance institutions, and engagement with multilateral development banks and international partners to leverage co-financing mechanisms; (4) a framework to sustain the role of faith-based and community-based service providers; (5) a plan to engage the private sector as key actors within the transition strategy; (6) guidance for the maintenance, integration, and nationalization of data systems used for performance tracking, oversight, and accountability; (7) a plan to safeguard personally identifiable information of patients within electronic medical records, laboratory systems, and surveillance systems required by new country agreements; and (8) post-transition engagement plans outlining how the United States will continue to partner with countries to maintain HIV epidemic control, ensure uninterrupted service, safeguard populations at risk, and protect gains made across health areas.”
KFF analysis of: PEPFAR and appropriations legislation, and accompanying explanatory statements and reports; U.S. Code, Title 22: Foreign Relations and Intercourse, <a href="https://www.govinfo.gov/app/details/USCODE-2024-title22/USCODE-2024-title22-chap83">Chapter 83 (UNITED STATES LEADERSHIP AGAINST HIV/AIDS, TUBERCULOSIS, AND MALARIA</a>; and <a href="https://www.govinfo.gov/app/details/USCODE-2024-title22/USCODE-2024-title22-chap32">Chapter 32 (FOREIGN ASSISTANCE), Sections 2151b - 2151b-4</a>; KFF, <a href="https://www.kff.org/global-health-policy/pepfar-reauthorization-side-by-side-of-legislation-over-time/">PEPFAR Reauthorization: Side-by-Side of Legislation Over Time</a>.
